Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer

PURPOSE: The first aim of the trial is to study feasibility of combined programmed death protein ligand 1/cytotoxic T-lymphocyte-associated protein 4 inhibition concomitant to radiotherapy. In addition, efficacy of the entire treatment scheme consisting of induction chemoimmunotherapy followed by ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Hecht, Markus, Eckstein, Markus, Rutzner, Sandra, von der Grün, Jens, Illmer, Thomas, Klautke, Gunther, Laban, Simon, Hautmann, Matthias G, Brunner, Thomas B, Tamaskovics, Bálint, Hinke, Axel, Zhou, Jian-Guo, Frey, Benjamin, Donaubauer, Anna-Jasmina, Becker, Ina, Semrau, Sabine, Hartmann, Arndt, Balermpas, Panagiotis, Budach, Wilfried, Gaipl, Udo S, Iro, Heinrich, Gostian, Antoniu-Oreste, Fietkau, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796267/
https://www.ncbi.nlm.nih.gov/pubmed/35078923
http://dx.doi.org/10.1136/jitc-2021-003747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796267/
https://www.ncbi.nlm.nih.gov/pubmed/35078923
http://dx.doi.org/10.1136/jitc-2021-003747

Ejemplares similares